These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 12884737)

  • 21. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Baillieres Clin Haematol; 1998 Jun; 11(2):509-14. PubMed ID: 10097823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
    Elliott MA; Nichols WL; Plumhoff EA; Ansell SM; Dispenzieri A; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Micallef IN; Tefferi A; Litzow M
    Mayo Clin Proc; 2003 Apr; 78(4):421-30. PubMed ID: 12683694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.
    Peyvandi F; Siboni SM; Lambertenghi Deliliers D; Lavoretano S; De Fazio N; Moroni B; Lambertenghi Deliliers G; Mannuccio Mannucci P
    Br J Haematol; 2006 Jul; 134(2):187-95. PubMed ID: 16846477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance].
    Korczowski B
    Med Wieku Rozwoj; 2005; 9(4):753-61. PubMed ID: 16733283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
    Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
    Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.
    Kokame K; Matsumoto M; Soejima K; Yagi H; Ishizashi H; Funato M; Tamai H; Konno M; Kamide K; Kawano Y; Miyata T; Fujimura Y
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11902-7. PubMed ID: 12181489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
    Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
    Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura.
    Yarranton H; Lawrie AS; Purdy G; Mackie IJ; Machin SJ
    Transfus Med; 2004 Feb; 14(1):39-44. PubMed ID: 15043592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Kremer Hovinga JA; Studt JD; Lämmle B
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).
    Plaimauer B; Zimmermann K; Völkel D; Antoine G; Kerschbaumer R; Jenab P; Furlan M; Gerritsen H; Lämmle B; Schwarz HP; Scheiflinger F
    Blood; 2002 Nov; 100(10):3626-32. PubMed ID: 12393399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
    Lattuada A; Rossi E; Calzarossa C; Candolfi R; Mannucci PM
    Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
    Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
    Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation between the level of von Willebrand factor-cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura.
    Snider CE; Moore JC; Warkentin TE; Finch CN; Hayward CP; Kelton JG
    Am J Hematol; 2004 Dec; 77(4):387-90. PubMed ID: 15551280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.
    Manea M; Karpman D
    Pediatr Nephrol; 2009 Mar; 24(3):447-58. PubMed ID: 18807073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.
    Veyradier A; Obert B; Houllier A; Meyer D; Girma JP
    Blood; 2001 Sep; 98(6):1765-72. PubMed ID: 11535510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis of thrombotic thrombocytopenic purpura].
    Budde U; Angerhaus D; Obser T; Schneppenheim R
    Hamostaseologie; 2004 Feb; 24(1):65-70. PubMed ID: 15029275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma.
    Kentouche K; Budde U; Furlan M; Scharfe V; Schneppenheim R; Zintl F
    Acta Paediatr; 2002; 91(10):1056-9. PubMed ID: 12434890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases.
    Franchini M; Montagnana M; Targher G; Lippi G
    Semin Thromb Hemost; 2007 Nov; 33(8):787-97. PubMed ID: 18175284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment.
    Hori Y; Hayakawa M; Isonishi A; Soejima K; Matsumoto M; Fujimura Y
    Transfusion; 2013 Dec; 53(12):3192-202. PubMed ID: 23560518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.